Home The factors associated with the failure of transcatheter pelvic arterial embolization for intractable postpartum hemorrhage
Article
Licensed
Unlicensed Requires Authentication

The factors associated with the failure of transcatheter pelvic arterial embolization for intractable postpartum hemorrhage

  • Yui Yamasaki , Hiroki Morita , Yoshiya Miyahara , Yasuhiko Ebina , Takuya Okada , Masato Yamaguchi and Hideto Yamada EMAIL logo
Published/Copyright: December 5, 2013

Abstract

Objective: The transcatheter pelvic arterial embolization (TAE) is effective for postpartum hemorrhage (PPH). There has been a little information about the factors for ineffectiveness of TAE. The aim of this study was to determine factors associated with TAE failure for PPH.

Study design: Fifty-five women who underwent TAE for intractable PPH were included. Clinical factors involving age, history of pregnancy, gestational weeks of delivery, mode of delivery, causes of PPH, complete blood count, blood loss volume, transfusion amount, shock index and disseminated intravascular coagulation (DIC) score were compared between TAE success group (n=48) and TAE failure group (n=7).

Results: The uni- and multi-variate analyses revealed that advanced maternal age (OR 1.46, 95% CI 1.12–2.18) and retained placenta as a cause of PPH (15.48, 2.04–198.12) were found to be significant factors for TAE failure.

Conclusion: The advanced age and retained placenta were independent factors associated with TAE failure for intractable PPH.


Corresponding author: Hideto Yamada, MD, PhD, Professor and Chairman, Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan, E-mail:

References

[1] Brown BJ, Heaston DK, Poulson AM, Gabert HA, Mineau DE, Miller FJ Jr. Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization. Obstet Gynecol. 1979;54:361–5.Search in Google Scholar

[2] Chantraine F, Blacher S, Berndt S, Palacios-Jaraquemada J, Sarioglu N, Nisolle M, et al. Abnormal vascular architecture at the placental-maternal interface in placenta increta. Am J Obstet Gynecol. 2012;207:188.e1–9.10.1016/j.ajog.2012.06.083Search in Google Scholar PubMed

[3] Chauleur C, Fanget C, Tourne G, Levy R, Larchez C, Seffert P. Serious primary post-partum hemorrhage, arterial embolization and future fertility: a retrospective study of 46 cases. Hum Reprod. 2008;23:1553–9.10.1093/humrep/den122Search in Google Scholar PubMed

[4] Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007;62:540–7.10.1097/01.ogx.0000271137.81361.93Search in Google Scholar PubMed

[5] Ganguli S, Stecker MS, Pyne D, Baum RA, Fan CM. Uterine artery embolization in the treatment of postpartum uterine hemorrhage. J Vasc Interv Radiol. 2011;22:169–76.10.1016/j.jvir.2010.09.031Search in Google Scholar PubMed

[6] Gonsalves M, Belli A. The role of interventional radiology in obstetric hemorrhage. Cardiovasc Intervent Radiol. 2010;33:887–95.10.1007/s00270-010-9864-4Search in Google Scholar PubMed

[7] Kato R. Maternal mortality in Japan and cardiopulmonary resuscitation in pregnancy. Masui. 2010;59:303–10.Search in Google Scholar

[8] Kim YJ, Yoon CJ, Seong NJ, Kang SG, An SW, Kim YS, et al. Failed pelvic arterial embolization for postpartum hemorrhage: clinical outcomes and predictive factors. J Vasc Interv Radiol. 2013;24:703–9.10.1016/j.jvir.2013.02.013Search in Google Scholar PubMed

[9] Kobayashi T, Terao T, Maki M, Ikenoue T. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost. 2001;27:161–7.10.1055/s-2001-14076Search in Google Scholar PubMed

[10] Lee HY, Shin JH, Kim J, Yoon HK, Ko GY, Won HS, et al. Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution. Radiology. 2012;264:903–9.10.1148/radiol.12111383Search in Google Scholar PubMed

[11] Naeye RL. Maternal age, obstetric complications, and the outcome of pregnancy. Obstet Gynecol. 1983;61:210–6.Search in Google Scholar

[12] Ornan D, White R, Pollak J, Tal M. Pelvic embolization for intractable postpartum hemorrhage: long-term follow-up and implications for fertility. Obstet Gynecol. 2003; 102(5 Pt 1):904–10.10.1097/00006250-200311000-00005Search in Google Scholar

[13] Pacagnella RC, Souza JP, Durocher J, Perel P, Blum J, Winikoff B, et al. A systematic review of the relationship between blood loss and clinical signs. J PLoS One. 2013;8:e57594.10.1371/journal.pone.0057594Search in Google Scholar PubMed PubMed Central

[14] Pelage JP, Le Dref O, Jacob D, Soyer P, Herbreteau D, Rymer R. Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand. 1999;78:698–703.Search in Google Scholar

[15] Pirhonen J, Bergersen TK, Abdlenoor M, Dubiel M, Gudmundsson S. Effect of maternal age on uterine flow impedance. J Clin Ultrasound. 2005;33:14–7.10.1002/jcu.20079Search in Google Scholar

[16] Poujade O, Zappa M, Letendre I, Ceccaldi PF, Vilgrain V, Luton D. Predictive factors for failure of pelvic arterial embolization for postpartum hemorrhage. Int J Gynaecol Obstet. 2012;117:119–23.10.1016/j.ijgo.2011.11.025Search in Google Scholar

[17] Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet 2006;368:1189–200.10.1016/S0140-6736(06)69380-XSearch in Google Scholar

[18] Sentilhes L, Gromez A, Clavier E, Resch B, Verspyck E, Marpeau L. Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. Obstet Gynecol. 2009;113:992–9.10.1097/AOG.0b013e3181a114f7Search in Google Scholar PubMed

[19] TeraoT, Maki M, Ikenoue T. A clinical and laboratory scoring system for DIC in the field of obstetrics. Blood & Vessel. 1986;17:543–54.10.2491/jjsth1970.17.543Search in Google Scholar

[20] Touboul C, Badiou W, Saada J, Pelage JP, Payen D, Vicaut E, et al. Efficacy of selective arterial embolisation for the treatment of life-threatening post-partum haemorrhage in a large population. PLoS One. 2008;3:e3819.10.1371/journal.pone.0003819Search in Google Scholar PubMed PubMed Central

[21] Tseng JJ, Chou MM, Hsieh YT, Wen MC, Ho ES, Hsu SL. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta. 2006;27:70–8.10.1016/j.placenta.2004.12.011Search in Google Scholar PubMed

[22] Uchiyama D, Koganemaru M, Abe T, Hori D, Hayabuchi N. Arterial catheterization and embolization for management of emergent or anticipated massive obstetrical hemorrhage. Radiat Med. 2008;26:188–97.10.1007/s11604-007-0213-8Search in Google Scholar PubMed

[23] Vegas G, Illescas T, Muñoz M, Pérez-Piñar A. Selective pelvic arterial embolization in the management of obstetric hemorrhage. Eur J Obstet Gynecol Reprod Biol. 2006;127:68–72.10.1016/j.ejogrb.2005.09.008Search in Google Scholar PubMed

The authors stated that there are no conflicts of interest regarding the publication of this article.

Received: 2013-9-6
Accepted: 2013-10-28
Published Online: 2013-12-5
Published in Print: 2014-5-1

©2014 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Academy’s Corner – a new section at JPM
  4. Academy’s Corner
  5. Global education in perinatal medicine: will the bureaucracy or smartocracy prevail?
  6. Review articles
  7. Placental chorioangioma: literature review
  8. Sonographic measurement of cervical length as a predictor of preterm delivery: a systematic review
  9. Original articles – Obstetrics
  10. Peripartum anesthetic management of patients with Factor XI deficiency
  11. Risk of inferior vena cava compression syndrome during fetal MRI in the supine position – a retrospective analysis
  12. Fetal behavioral states are stable over daytime – evidence by longitudinal and cross-sectional fetal biomagnetic recordings
  13. Diet or medically treated gestational diabetes: is there any difference for obstetrical and neonatal complications? A French cohort study
  14. Cerebroplacental Doppler ratio and placental histopathological features in pregnancies complicated by fetal growth restriction
  15. Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia
  16. Pharmacological anti-thrombotic prophylaxis after elective caesarean delivery in thrombophilia unscreened women: should maternal age have a role in decision making?
  17. Values of T/QRS ratios measured during normal and post-term pregnancies
  18. The factors associated with the failure of transcatheter pelvic arterial embolization for intractable postpartum hemorrhage
  19. Hysteroscopic and laparoscopic management of uterine defects on previous cesarean delivery scars
  20. Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy
  21. Repetitive administration of acetylcholine receptor agonist rescues brain inflammation and brain damage after hypoxia-ischemia in newborn rat
  22. Original article – Fetus
  23. Fetal hydronephrosis: natural history and risk factors for postnatal surgery
  24. Original article – Newborn
  25. Cytomegalovirus infection among infants in California neonatal intensive care units, 2005–2010
  26. Letter to the Editors
  27. Origin of the long-term variability and acceleration of FHR studied for the prevention of cerebral palsy in fetal hypoxia and general insults
  28. Neonatal phototherapy, fluids, and photorelaxation
  29. Congress Calendar
  30. Congress Calendar
Downloaded on 28.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2013-0242/html
Scroll to top button